New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribose) polymerases (PARPs) are enzymes that transfer ADP-ribose groups to target proteins and thereby affect various nuclear and cytoplasmic processes. The activity of PARP family members, such as PARP1 and PARP2, is tied to cellular signalling pathways, and through poly(ADP-ribosyl)ation (PARylation) they ultimately promote changes in gene expression, RNA and protein abundance, and the location and activity of proteins that mediate signalling responses. PARPs act in a complex response network that is driven by the cellular, molecular and chemical biology of poly(ADP-ribose) (PAR). This PAR-dependent response network is crucial for a broad array of physiological and pathological responses and thus is a good target for chemical therapeutics for several diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated PARP1 will consume NAD+, generating PAR through a process called PARylation82.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [82]
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Cited by
Items 401–500 of 1,000
Nucleotide excision repair leaves a mark on chromatin: DNA damage detection in nucleosomes
Apelt, K., Lans, H., Schärer, O. D., & Luijsterburg, M. S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03984-7 · Cited by 46
PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword
Csizmar, C. M., Saliba, A. N., Swisher, E. M., & Kaufmann, S. H. (2021) · Cancers · doi:10.3390/cancers13246385 · Cited by 45
“Seventeen other PARP family members have been identified based on their structural homology to PARP1 [45].”
BackgroundPoly (ADP-ribose) polymerase 1 and neurodegenerative diseases: past, present, and future
Hu, M.-L., Pan, Y.-R., Yong, Y.-Y., Liu, Y., Yu, L., Qin, D.-L., Qiao, G., Law, B. Y.-K., Wu, J.-M., Zhou, X.-G., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102078 · Cited by 44
Chen, Y., Xu, X., Wang, Y.-R., Zhang, Y.-D., Zhou, T., Jiang, W.-J., Wang, Z.-Y., Chang, J., Liu, S.-C., Chen, R.-X., et al. (2023) · Journal of experimental & clinical cancer research : CR · doi:10.1186/s13046-023-02842-7 · Cited by 43
“PARylation is mainly mediated by poly (ADP-ribose) polymerase (PARP), which transfers ADP-ribose to specific amino acid groups of receptor proteins to form poly (ADP-ribose) chains [19].”
BackgroundYao, H., Ji, M., Zhu, Z., Zhou, J., Cao, R., Chen, X., & Xu, B. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.071 · Cited by 44
RecQ helicases and PARP1 team up in maintaining genome integrity
Veith, S., & Mangerich, A. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.12.006 · Cited by 49
Konstantakou, E. G., Voutsinas, G. E., Velentzas, A. D., Bassogianni, A.-S., Paronis, E., Balafas, E., Kostomitsopoulos, N. G., Syrigos, K. N., Anastasiadou, E., & Stravopodis, D. J. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0399-9 · Cited by 45
“activation has been previously implicated in necrotic death [18, 19], PJ-34, a PARP-specific inhibitor [18, 20], was”
BackgroundInfluentialInhibiting poly(ADP-ribosylation) improves axon regeneration
Byrne, A. B., McWhirter, R. D., Sekine, Y., Strittmatter, S. M., Miller, D. M., & Hammarlund, M. (2016) · eLife · doi:10.7554/elife.12734 · Cited by 44
“PARylation is a short-lived modification, and PAR levels are normally maintained by the continuous activity of PARP and PARG proteins (Schreiber et al., 2006; Gibson and Kraus, 2012).”
BackgroundPoly(ADP-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions
Kumbhar, R., Sanchez, A. R., Perren, J. O., Gong, F., Corujo, D., Medina, F., Devanathan, S. K., Xhemalçe, B., Matouschek, A. T., Buschbeck, M., et al. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202006149 · Cited by 44
Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration
Wangpaichitr, M., Theodoropoulos, G., Nguyen, D. J. M., Wu, C., Spector, S. A., Feun, L. G., & Savaraj, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147379 · Cited by 47
“Using NAD+ as a substrate, PARP‐1 repeatedly catalyzes the transfer of successive units of ADP‐ribose moieties, via a unique 2′,1′′‐O‐ glycosidic ribose‐ribose bond, to target proteins, finally producing the PAR chain [115].”
BackgroundShao, C., Qiu, Y., Liu, J., Feng, H., Shen, S., Saiyin, H., Yu, W., Wei, Y., Yu, L., Su, W., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0906-1 · Cited by 44
Krieg, S., Pott, F., Potthoff, L., Verheirstraeten, M., Bütepage, M., Golzmann, A., Lippok, B. E., Goffinet, C., Lüscher, B., & Korn, P. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04717-8 · Cited by 43
“PARylation is best known for its function in the DNA damage response, but has also been linked to chromatin organization, ribosome biogenesis, telomere maintenance, signaling processes and cell death [1, 23, 24].”
BackgroundG-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting
Romano, F., Porzio, A. D., Iaccarino, N., Riccardi, G., Lorenzo, R. D., Laneri, S., Pagano, B., Amato, J., & Randazzo, A. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2271168 · Cited by 47
“The PARP1 gene encodes a chromatin-associated enzyme, the poly (ADP-ribose) polymerase-1, which modifies various nuclear proteins by poly (ADP-ribosyl)ation and plays a key role in DNA repair [336,337].”
BackgroundReal‐Time Cellular Imaging of Protein Poly(ADP‐ribos)ylation
Buntz, A., Schlesiger, S., Gwosch, E., Schmalz, M. F., Beneke, S., Ferrando‐May, E., Marx, A., & Zumbusch, A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201605282 · Cited by 43
The nucleosomal surface is the main target of histone ADP-ribosylation in response to DNA damage
Karch, K. R., Langelier, M.-F., Pascal, J. M., & Garcia, B. A. (2017) · Molecular BioSystems · doi:10.1039/c7mb00498b · Cited by 43
Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis
Zhang, Y., Pötter, S., Chen, C., Liang, R., Gelse, K., Ludolph, I., Horch, R. E., Distler, O., Schett, G. A., Distler, J. H. W., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212265 · Cited by 43
Wang, Z., Grosskurth, S. E., Cheung, T., Petteruti, P., Zhang, J., Wang, X., Wang, W., Gharahdaghi, F., Wu, J., Su, N., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1362 · Cited by 44
“5 be further divided into poly(ADP‐ribose) generating PARPs such as PARPs 1‐5, catalytically inactive PARPs such as PARPs 9 and 13, and mono(ADP‐ribose) generating PARPs such as PARPs 6‐8, 10‐12, and 14‐15 [14, 15].”
BackgroundGu, Z., Pan, W., Chen, W., Lian, Q., Wu, Q. Y., Lv, Z., Cheng, X., & Ge, X. (2019) · BMC Plant Biology · doi:10.1186/s12870-019-1958-9 · Cited by 44
Macro domains as metabolite sensors on chromatin
Marjanović, M. P., Timinszky, G., & Buschbeck, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1294-4 · Cited by 43
Wang, J., Zhu, C., Song, D., Xia, R., Yu, W., Dang, Y., Fei, Y., Yu, L., & Wu, J. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.34 · Cited by 43
Mangerich, A., Dębiak, M., Birtel, M., Ponath, V., Balszuweit, F., Lex, K., Martello, R., Burckhardt-Boer, W., Strobelt, R., Siegert, M., et al. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.09.010 · Cited by 42
“Activated PARPs use NAD + as a substrate to synthesize the nucleic acid like biopolymer poly(ADP ribose) (PAR) with chain lengths of up to 200 ADP ribose units (Gibson and Kraus, 2012; Martello et al., 2013).”
BackgroundSynthetic lethality and cancer: cohesin and PARP at the replication fork
O’Neil, N. J., van Pel, D. M., & Hieter, P. (2013) · Trends in Genetics · doi:10.1016/j.tig.2012.12.004 · Cited by 48
Yu, C., Kim, B., & Kim, E. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.99 · Cited by 45
Su, L., Shi, Y., Mei-rong, Y., Xi, Y., & Su, X. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.80 · Cited by 41
Poly ADP-ribose polymerase-1: Beyond transcription and towards differentiation
Jubin, T., Kadam, A. A., Gani, A. R., Singh, M., Dwivedi, M., & Begum, R. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.07.027 · Cited by 42
MicroRNAs Modulate Oxidative Stress in Hypertension through PARP‐1 Regulation
Dluzen, D. F., Kim, Y., Bastian, P., Zhang, Y., Lehrmann, E., Becker, K. G., Hooten, N. N., & Evans, M. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3984280 · Cited by 42
Single-molecule measurements reveal that PARP1 condenses DNA by loop stabilization
Bell, N. A. W., Haynes, P. J., Brunner, K., de Oliveira, T. M., Flocco, M. M., Hoogenboom, B. W., & Molloy, J. E. (2021) · Science Advances · doi:10.1126/sciadv.abf3641 · Cited by 44
“The human genome encodes 17 PARP family genes, which play a wide variety of roles in cellular processes (1, 2), with PARP1 accounting for 90% of ADP-ribose synthesis (3).”
BackgroundMajuelos‐Melguizo, J., Rodríguez, M. I., López-Jiménez, L., Rodríguez-Vargas, J. M., Martí, J. M., Serrano, S., Gavard, J., de Almodóvar, J. M. R., & Oliver, F. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2993 · Cited by 44
Synthesis and Macrodomain Binding of Mono‐ADP‐Ribosylated Peptides
Kistemaker, H. A. V., Nardozza, A. P., Overkleeft, H. S., van der MAREL, G. A., Ladurner, A. G., & Filippov, D. V. (2016) · Angewandte Chemie · doi:10.1002/ange.201604058 · Cited by 40
Ríos‐Marco, P., Romero‐López, C., & Berzal‐Herranz, A. (2016) · Scientific Reports · doi:10.1038/srep25729 · Cited by 54
Proteomic Analysis of the Downstream Signaling Network of PARP1
Zhen, Y., & Yu, Y. (2018) · Biochemistry · doi:10.1021/acs.biochem.7b01022 · Cited by 42
“It has been shown that, in the context of PAR-catabolism, TARG1 is able to complement PARG, by (1) hydrolyzing the glutamate-ADP-ribose ester bond, and thus removing the entire PAR chain from a PARylated protein, (2) reversing protein MARylation, and (3) completing the removal of the terminal ADP-ribose following the…”
BackgroundInfluentialDecreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition
Wang, W., Hu, Y., Yang, C., Zhu, S., Wang, X., Zhang, Z., & Deng, H. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000882 · Cited by 39
“nuclear proteins in cellular stress responses (21, 22) that”
BackgroundBuranasudja, V., Doskey, C. M., Gibson, A. R., Wagner, B. A., Du, J., Gordon, D. J., Koppenhafer, S. L., Cullen, J. J., & Buettner, G. R. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0381 · Cited by 41
“Activation of PARP1 in response to DNA damage leads to poly(ADP-ribosyl)ation, extensive consumption of NADþ, depletion of ATP, and the possible induction of cell death (27, 44, 45).”
BackgroundPost-Translational Modifications in Oocyte Maturation and Embryo Development
Wu, Y., Li, M., & Yang, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645318 · Cited by 44
Lee, S.-A., Lee, D., Kang, M., Kim, S., Kwon, S.-J., Lee, H.-S., Seo, H.-R., Kaushal, P., Lee, N. S., Kim, H., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01024-w · Cited by 45
Qiu, G., Xie, J., Li, F., Han, K., Long, Q., Kowah, J. A. H., Gao, R., Wang, L., & Liu, X. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116348 · Cited by 40
Mechanisms of oncogenic chromosomal translocations
Byrne, M. T., Wray, J. W., Reinert, B. L., Wu, Y., Nickoloff, J. A., Lee, S., Hromas, R., & Williamson, E. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12370 · Cited by 39
LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer
Wu, F., Chen, Y., & Zhu, J. (2020) · Bioscience Reports · doi:10.1042/bsr20194142 · Cited by 39
TSG101 associates with PARP1 and is essential for PARylation and DNA damage‐induced NF‐κB activation
Tufan, A. B., Lazarow, K., Kolesnichenko, M., Sporbert, A., von Kries, J. P., & Scheidereit, C. (2022) · The EMBO Journal · doi:10.15252/embj.2021110372 · Cited by 45
“ADP-ribose modification is one of the most crucial regulatory PTMs found in eukaryotes (Gibson & Kraus, 2012).”
Deciphering the Insights of Poly(ADP-Ribosylation) in Tumor Progression
Rodríguez, M. I., Majuelos‐Melguizo, J., Martí, J. M., de Almodóvar, J. M. R., López‐Rivas, A., & Oliver, F. J. (2015) · Medicinal Research Reviews · doi:10.1002/med.21339 · Cited by 40
“(2) The group of PARPs called tankyrases contains large ankyrin domain repeats to facilitate protein–protein interactions.”
BackgroundA Clickable Aminooxy Probe for Monitoring Cellular ADP-Ribosylation
Morgan, R. K., & Cohen, M. S. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00213 · Cited by 39
McGurk, L., Gomes, E., Guo, L. E., Shorter, J., & Bonini, N. M. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00910 · Cited by 38
Nudix Hydrolase NUDT16 Regulates 53BP1 Protein by Reversing 53BP1 ADP-Ribosylation
Zhang, F., Lou, L., Peng, B., Song, X., Reizes, O., Almasan, A., & Gong, Z. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2205 · Cited by 40
Grolla, A. A., Miggiano, R., Marino, D. D., Bianchi, M., Gori, A., Orsomando, G., Gaudino, F., Galli, U., Grosso, E. D., Mazzola, F., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010571 · Cited by 40
“NAD is a rate-limiting substrate for mono- and polyADP-ribose transferases (including poly(ADP-ribose) polymerases; PARPs)(4) (6), cyclic ADP-ribose synthases (CD38 and CD157) (7), SARM1 (8), and sirtuins (9).”
BackgroundMcLaughlin, L. J., Stojanovic, L., Kogan, A. A., Rutherford, J. L., Choi, E. Y., Yen, R.-W. C., Xia, L., Zou, Y. S., Lapidus, R. G., Baylin, S. B., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003499117 · Cited by 41
“PARP1 is an abundant nuclear protein that senses and contributes to repair of DNA single-strand breaks (SSBs) (1, 2), working through catalyzing poly-(ADP ribosyl)ation, or PARylation, of itself, histones, and other target proteins (3).”
BackgroundBiochemical genesis of enzymatic and non-enzymatic post-translational modifications
Jennings, E. Q., Fritz, K. S., & Galligan, J. J. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101053 · Cited by 43
Targeting NAD+ metabolism: dual roles in cancer treatment
Yong, J., Cai, S., & Zeng, Z.-L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1269896 · Cited by 40
Update on Combination Strategies of PARP Inhibitors
Lin, Z., Wang, L., Xing, Z., Wang, F., & Cheng, X. (2024) · Cancer Control · doi:10.1177/10732748241298329 · Cited by 44
“13 To repair DNA damage and preserving genomic integrity, PARP1/2 is crucial.”
BackgroundInfluentialZhao, Q., Guan, J., Qin, Y., Ren, P., Zhang, Z., Lv, J., Sun, S., Zhang, C., & Mao, W. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.078 · Cited by 39
The promising PARP inhibitors in ovarian cancer therapy: From Olaparib to others
Chen, Y., & Du, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.094 · Cited by 39
RUNX Poly(ADP-Ribosyl)ation and BLM Interaction Facilitate the Fanconi Anemia Pathway of DNA Repair
Tay, L. S., Krishnan, V., Sankar, H., Chong, Y. L., Chuang, L. S. H., Tan, T. Z., Kolinjivadi, A. M., Kappei, D., & Ito, Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.038 · Cited by 37
Janisiw, E., Raices, M., Balmir, F., Paulin, L. F., Baudrimont, A., von Haeseler, A., Yanowitz, J. L., Jantsch, V., & Silva, N. (2020) · Nature Communications · doi:10.1038/s41467-020-18693-1 · Cited by 38
PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
Kontandreopoulou, C., Diamantopoulos, P. T., Tiblalexi, D., Giannakopoulou, N., & Viniou, N. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004638 · Cited by 39
Poly(ADP-Ribose)Polymerase Activity Controls Plant Growth by Promoting Leaf Cell Number
Schulz, P., Jansseune, K., Degenkolbe, T., Méret, M., Claeys, H., Skirycz, A., Teige, M., Willmitzer, L., & Hannah, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090322 · Cited by 36
“In mammals, 18 PARP or PARP-like proteins are so far described [20] and are linked to several processes as recently reviewed like DNA damage repair, transcriptional regulation, chromatin status, the circadian clock, metabolism or the proteasome [21–24].”
Schuhwerk, H., Bruhn, C., Siniuk, K., Min, W., Erener, S., Grigaravičius, P., Krüger, A., Ferrari, E. S., Zubel, T., Lázaro, D. R., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx717 · Cited by 36
“PARylation or PAR can target a variety of proteins that bind PAR via different PAR-binding motifs, which are thought to provide a spatiotemporal interaction scaffold (4,6,7).”
BackgroundDNA Damage Response Regulates Initiation of Liver Regeneration Following Acetaminophen Overdose
Borude, P., Bhushan, B., & Apte, U. (2018) · Gene Expression · doi:10.3727/105221618x15205260749346 · Cited by 35
Avoid the trap: Targeting PARP1 beyond human malignancy
Kim, C., Chen, C., & Yu, Y. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.02.004 · Cited by 40
“PARP1 is a Poly(ADP-ribose) polymerase (PARP) enzyme that is critically involved in regulating cell stress responses (Gibson and Kraus, 2012).”
BackgroundPleiotropic role of PARP1: an overview
Kumar, V., Kumar, A., Mir, K. U. I., Yadav, V., & Chauhan, S. S. (2021) · 3 Biotech · doi:10.1007/s13205-021-03038-6 · Cited by 38
“The significance of PARP1 has been established in multiple DNA repair mechanisms, notably in base excision repair (BER), nucleotide excision repair (NER), and pathways involving double-strand break repair (DSB), such as non-homologous end joining (NHEJ) (D’Amours et al. 1999; Krishnakumar and Kraus 2010; Gibson and Kr…”
BackgroundInfluentialPersistent DNA damage associated with ATM kinase deficiency promotes microglial dysfunction
Bourseguin, J., Cheng, W., Talbot, E., Hardy, L., Lai, J. F., Jeffries, A. M., Lodato, M. A., Lee, E. A., & Khoronenkova, S. V. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac104 · Cited by 38
“Protein poly[ADP-ribosyl]ation (PAR) that occurs at sites of DNA single-(SSBs) and double-strand breaks (DSBs) and phosphorylation of histone variant H2AX at S139 ( (cid:7) H2AX), which marks DSBs (4,58), were increased in ATM-deficient cells (Figures 5A and 5B).”
Merecz-Sadowska, A., Markiewicz, Ł., Śliwińska, A., Kosmalski, M., Kasznicki, J., Drzewoski, J., & Majsterek, I. (2015) · Advances in Medical Sciences · doi:10.1016/j.advms.2015.04.001 · Cited by 36
Bornhorst, J., Meyer, S., Weber, T., Böker, C., Marschall, T. A., Mangerich, A., Beneke, S., Bürkle, A., & Schwerdtle, T. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200758 · Cited by 38
“PARP-1 is responsible for about 90% of cellular poly(ADP-ribose) (PAR) formation [22, 23].”
BackgroundThe Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer
Luo, J., Jin, J., Yang, F., Sun, Z., Zhang, W., Shi, Y., Xu, J., & Guan, X. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.16176 · Cited by 38
“In DNA damage repair (DDR) process, PARP1 plays a curial role in the base-excision repair (BER) pathway for DNA single-strand breaks repair while DNA double-strand breaks are mainly repaired by homologous recombination repair (HRR) pathway in which BRCA1 has an important role [15-17].”
BackgroundCTCF participates in DNA damage response via poly(ADP-ribosyl)ation
Han, D., Chen, Q., Shi, J., Zhang, F., & Yu, X. (2017) · Scientific Reports · doi:10.1038/srep43530 · Cited by 36
“Since PAR is one of the early signals at the sites of DNA damage 7,19 , CTCF is quickly recruited to DNA lesions within 30 seconds.”
PARP Inhibition Delays Progression of Mitochondrial Encephalopathy in Mice
Felici, R., Cavone, L., Lapucci, A., Guasti, D., Bani, D., & Chiarugi, A. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0285-y · Cited by 37
“PAR content is reduced in KOmice upon PJ34 administration, which is in keeping with the notion that PARP-1 contributes to the majority of PAR formations [13, 14].”
Cytoplasmic PARP‐1 promotes pancreatic cancer tumorigenesis and resistance
Xu, F., Sun, Y., Yang, S., Zhou, T., Jhala, N. C., McDonald, J. M., & Chen, Y. (2019) · International Journal of Cancer · doi:10.1002/ijc.32108 · Cited by 35
The PARP Way to Epigenetic Changes
Ummarino, S., Hausman, C., & Ruscio, A. D. (2021) · Genes · doi:10.3390/genes12030446 · Cited by 37
“These interactions might lead to recruitment and integration of histone variants to specific genomic sites and control PARP1 function [30,31].”
BackgroundIpsen, M. B., Sørensen, E. M. G., Thomsen, E. A., Weiss, S., Haldrup, J., Dalby, A., Palmfeldt, J., Bross, P., Rasmussen, M. K., Fredsøe, J., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02427-2 · Cited by 35
“These genes have not previously been described in relation to PARPi resistance, but have been linked to various DNA repair pathways (ARH3: base excision repair [20]; CCND1, TEAD4, UBR5, and YWHAE: homologous recombination [21–24]; USP48: Fanconi’s Anemia pathway [25]).”
BackgroundTargeting dePARylation for cancer therapy
Kassab, M. A., Yu, L. L., & Yu, X. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-0375-y · Cited by 35
DNA-repair in mild cognitive impairment and Alzheimer's disease
Bucholtz, N., & Demuth, I. (2013) · DNA Repair · doi:10.1016/j.dnarep.2013.07.005 · Cited by 34
RACK1 MARylation regulates translation and stress granules in ovarian cancer cells
Challa, S., Nandu, T. S., Kim, H. B., Gong, X., Renshaw, C. W., Li, W.-C., Tan, X., Aljardali, M. W., Camacho, C. V., Chen, J., et al. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202401101 · Cited by 36
Self-citationPARPs and PARP inhibitors: molecular mechanisms and clinical applications
Wang, F., Zhuyi, G. U. O., Carr, M. J., & Shi, W. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00385-1 · Cited by 40
“This activity initiates and coordinates various repair pathways, including BER, single-strand break repair (SSBR), and double-strand break repair (DSBR) [43, 44].”
Concepts and Molecular Aspects in the Polypharmacology of PARP‐1 Inhibitors
Passeri, D., Camaioni, E., Liscio, P., Sabbatini, P., Ferri, M., Carotti, A., Giacchè, N., Pellicciari, R., Gioiello, A., & Macchiarulo, A. (2015) · ChemMedChem · doi:10.1002/cmdc.201500391 · Cited by 34
Martino‐Echarri, E., Brocardo, M. G., Mills, K. M., & Henderson, B. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150484 · Cited by 34
Poly(ADP-ribosyl)ated PXR is a critical regulator of acetaminophen-induced hepatotoxicity
Wang, C., Xu, W., Zhang, Y., Huang, D., & Huang, K. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0875-4 · Cited by 34
Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14)
Schweiker, S. S., Tauber, A. L., Sherry, M. E., & Levonis, S. M. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557518666180816111749 · Cited by 38
DNA‑PKcs PARylation regulates DNA‑PK kinase activity in the DNA damage response
Yang, H., Jin, F., Xie, Y., Liu, Y., Hu, S., Liu, X., Guan, H., Gu, Y., Ma, T., & Zhou, P. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10640 · Cited by 34
A Bifunctional NAD+ for Profiling Poly-ADP-Ribosylation-Dependent Interacting Proteins
Lam, A. T., Zhang, X., Courouble, V. V., Strutzenberg, T. S., Pei, H., Stiles, B. L., Louie, S. G., Griffin, P. R., & Zhang, Y. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00937 · Cited by 36
ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12
Li, L., Shi, Y., Li, S., Liu, J., Zu, S., Xu, X., Gao, M., Sun, N., Pan, C., Peng, L., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00628-y · Cited by 37
The Role of MacroH2A Histone Variants in Cancer
Hsu, C.-J., Meers, O., Buschbeck, M., & Heidel, F. H. (2021) · Cancers · doi:10.3390/cancers13123003 · Cited by 36
Transcription-coupled DNA double-strand break repair
Guha, S., & Bhaumik, S. R. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103211 · Cited by 35
MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression
Giansanti, C., Manzini, V., Dickmanns, A., Dickmanns, A., Palumbieri, M. D., Sanchi, A., Kienle, S. M., Rieth, S., Scheffner, M., Lopes, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110879 · Cited by 37
“PARylation of proteins regulates their function, localization, and stability (Gibson and Kraus, 2012).”
BackgroundDiani-Moore, S., Zhang, S., Ram, P., & Rifkind, A. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458067 · Cited by 37
Hailei, Z., Gu, Z., Wu, Q. Y., Yang, L., Liu, C., Mā, H., Xia, Y., & Ge, X. (2015) · Scientific Reports · doi:10.1038/srep15892 · Cited by 36
PARP1 UFMylation ensures the stability of stalled replication forks
Gong, Y., Wang, Z., Zong, W., Shi, R., Sun, W., Wang, S., Peng, B., Takeda, S., Wang, Z., & Xu, X. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2322520121 · Cited by 38
“PARP1 is a multiple functional protein: It is activated by oxidative DNA damage and SSBs to recruit BER machinery (39, 48, 52), and helps to regulate DSBs, promoting the microhomology - mediated end joining at DSBs (14, 53, 54).”
BackgroundPARP1 stabilizes FOXN3 to suppress pulmonary fibrosis through p38-related feedback regulation
Zhu, X., Huo, Q., Jin, L., Du, J., Yu, J., Wang, H., Wu, N., Li, Y., Rui, Y., Zhao, C., et al. (2026) · Science Advances · doi:10.1126/sciadv.ady1681 · Cited by 36
“This modification, referred to as poly(ADP-ribosyl)ation (PARylation), affects protein stability and subcellular localization, playing a vital role in the regulation of numerous biological processes ( 39 ).”
NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair
Wang, P., Li, W.-L., Liu, J.-M., & Miao, C.-Y. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000332 · Cited by 32
“PARPs are a family of enzymes that use the ADP-ribose groups in NAD to form branched ADP-ribose polymers to repair DNA strand breaks or kinks.(15) CD38 is a surface receptor and an enzyme metabolizing NAD to generate Ca2+-mobilizing messengers, including cyclic ADP ribose and ADP ribose.”
BackgroundIdentification of PARP14 inhibitors using novel methods for detecting auto-ribosylation
Yoneyama-Hirozane, M., Matsumoto, S.-I., Toyoda, Y., Saikatendu, K. S., Zama, Y., Yonemori, K., Oonishi, M., Ishii, T., & Kawamoto, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.052 · Cited by 35
Васильева, И. А., Moor, N. A., Anarbaev, R. O., Kutuzov, M. M., & Lavrik, O. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094679 · Cited by 30
Lu, B., Chen, X., Liu, X., Chen, J., Qin, H., Chen, S., & Zhao, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03802-z · Cited by 34
The Rheumatoid Arthritis Risk Variant CCR6DNP Regulates CCR6 via PARP-1
Li, G., Cunin, P., Wu, D., Diogo, D., Yang, Y., Okada, Y., Plenge, R. M., & Nigrovic, P. A. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006292 · Cited by 34
“PARP-1 is the founding member of a family of enzymes engaged in transfer of poly ADPribose (PAR) to a wide range of nuclear and cytoplasmic proteins, including PARP-1 itself [10,27].”
BackgroundDynamic light scattering study of base excision DNA repair proteins and their complexes
Васильева, И. А., Anarbaev, R. O., Moor, N. A., & Lavrik, O. I. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.10.009 · Cited by 33
Role of PARP-1 in prostate cancer.
Deshmukh, D., & Qiu, Y. (2015) · Europe PMC (PubMed Central) · Cited by 41
Sun, Z., Li, L., Zhai, B., Hu, M., Huang, L. H., Huang, S., Liu, Y., Kong, X., Xu, J. C., Bai, J., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00077 · Cited by 35
TheStreptococcus pyogenes NAD+glycohydrolase modulates epithelial cell PARylation and HMGB1 release
Chandrasekaran, S., & Caparon, M. G. (2015) · Cellular Microbiology · doi:10.1111/cmi.12442 · Cited by 33
“This protein resides in the nucleus where it performs a broad spectrum of stress-related functions including DNA damage control, transcriptional activation, chromatin modulation, cell division and inflammation (Gibson and Kraus, 2012).”
BackgroundGrabowski, J. M., Gulia-Nuss, M., Kuhn, R. J., & Hill, C. A. (2017) · Parasites & Vectors · doi:10.1186/s13071-016-1944-0 · Cited by 33
“Small molecule inhibitors of FAH [57, 58] and PARP [59, 60] are known but their potential to regulate flavivirus infection in arthropods has not been investigated.”
AHR toxicity and signaling: Role of TIPARP and ADP-ribosylation
Matthews, J. B. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.01.013 · Cited by 36
Lv, S., Ju, C., Peng, J., Liang, M., Zhu, F., Wang, C., Huang, K., Cheng, M., & Zhang, F. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.35075 · Cited by 34
Selective inhibition of PARP10 using a chemical genetics strategy
Morgan, R. K., Carter-O’Connell, I., & Cohen, M. S. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.07.033 · Cited by 32
Function and Regulation of the Mono-ADP-Ribosyltransferase ARTD10
Kaufmann, M., Feijs, K. L. H., & Lüscher, B. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_379 · Cited by 35
PARP6 is a Regulator of Hippocampal Dendritic Morphogenesis
Huang, J. Y., Wang, K., Vermehren‐Schmaedick, A., Adelman, J. P., & Cohen, M. S. (2016) · Scientific Reports · doi:10.1038/srep18512 · Cited by 32
Metadata
- Authors
- Gibson, B. A., & Kraus, W. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Kraus, W. Lee
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-06-20
- Volume
- 13
- Issue
- 7
- Pages
- 411-424
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1965006127
- Cited by
- 1,226
- References
- 128
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 76 · 2023: 84 · 2022: 94 · 2021: 113 · 2020: 108 · 2019: 83 · 2018: 97 · 2017: 94 · 2016: 86 · 2015: 91 · 2014: 77 · 2013: 79 · 2012: 7
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- poly(ADP-ribosyl)ation, poly(ADP-ribose), PARP1, PARP2, PARP family, protein modification, signal transduction, gene expression regulation, PARP inhibitors
- MeSH terms
- Animals, Catalysis, Cell Nucleus, Cherubism, Cytoplasm, Gene Expression Regulation, Humans, Models, Molecular, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Polymers, Protein Conformation, Protein Processing, Post-Translational, RNA, Signal Transduction, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.